Feasibility and surgical outcomes of laparoscopic metastasectomy in the treatment of ovarian metastases from gastric cancer

Maria Lee, Jiheum Paek, San Hui Lee, Ga Won Yim, Sang Wun Kim, Sunghoon Kim, Jae-Hoon Kim, YoungTae Kim, Eun Ji Nam

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Objectives: This study aimed to evaluate the feasibility of laparoscopic metastasectomy (LM) in the treatment of ovarian metastases from gastric cancer and to compare the surgical outcomes with patients who underwent open metastasectomy (OM). Methods: The cases of 73 patients who underwent LM (n = 16) or OM (n = 57) were retrospectively reviewed. All patients were diagnosed with gastric cancer and, subsequently, underwent a metastasectomy at Yonsei University Health System between December 2002 and March 2011. Results: Sixteen operations were completed laparoscopically with no conversion to laparotomy. Complete cytoreduction surgery was achievable in 13 patients (81.3%). Operating time, complete cytoreduction, and occurrence of perioperative complications were comparable between the 2 groups. The LM group had less blood loss (25 vs 400 mL, P < 0.0001), earlier return to a general diet (3 vs 4 days, P = 0.005), shorter postoperative hospital stay (4.5 vs 7 days, P < 0.0001), and lower postoperative pain scores after 6, 24, and 48 hours than those in the OM group. There were no operative complications in the LM group. Conclusions: As a surgical treatment for ovarian metastases from gastric cancer, LM is feasible and provides benefits to patients without detrimental effects on the clinical outcomes for selected patients.

Original languageEnglish
Pages (from-to)1306-1311
Number of pages6
JournalInternational Journal of Gynecological Cancer
Volume21
Issue number7
DOIs
Publication statusPublished - 2011 Oct 1

Fingerprint

Metastasectomy
Stomach Neoplasms
Neoplasm Metastasis
Therapeutics
Postoperative Pain
Laparotomy
Length of Stay
Diet

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Lee, Maria ; Paek, Jiheum ; Lee, San Hui ; Yim, Ga Won ; Kim, Sang Wun ; Kim, Sunghoon ; Kim, Jae-Hoon ; Kim, YoungTae ; Nam, Eun Ji. / Feasibility and surgical outcomes of laparoscopic metastasectomy in the treatment of ovarian metastases from gastric cancer. In: International Journal of Gynecological Cancer. 2011 ; Vol. 21, No. 7. pp. 1306-1311.
@article{3f529bbb4419424c9b26d1e4ce044c34,
title = "Feasibility and surgical outcomes of laparoscopic metastasectomy in the treatment of ovarian metastases from gastric cancer",
abstract = "Objectives: This study aimed to evaluate the feasibility of laparoscopic metastasectomy (LM) in the treatment of ovarian metastases from gastric cancer and to compare the surgical outcomes with patients who underwent open metastasectomy (OM). Methods: The cases of 73 patients who underwent LM (n = 16) or OM (n = 57) were retrospectively reviewed. All patients were diagnosed with gastric cancer and, subsequently, underwent a metastasectomy at Yonsei University Health System between December 2002 and March 2011. Results: Sixteen operations were completed laparoscopically with no conversion to laparotomy. Complete cytoreduction surgery was achievable in 13 patients (81.3{\%}). Operating time, complete cytoreduction, and occurrence of perioperative complications were comparable between the 2 groups. The LM group had less blood loss (25 vs 400 mL, P < 0.0001), earlier return to a general diet (3 vs 4 days, P = 0.005), shorter postoperative hospital stay (4.5 vs 7 days, P < 0.0001), and lower postoperative pain scores after 6, 24, and 48 hours than those in the OM group. There were no operative complications in the LM group. Conclusions: As a surgical treatment for ovarian metastases from gastric cancer, LM is feasible and provides benefits to patients without detrimental effects on the clinical outcomes for selected patients.",
author = "Maria Lee and Jiheum Paek and Lee, {San Hui} and Yim, {Ga Won} and Kim, {Sang Wun} and Sunghoon Kim and Jae-Hoon Kim and YoungTae Kim and Nam, {Eun Ji}",
year = "2011",
month = "10",
day = "1",
doi = "10.1097/IGC.0b013e31822620e3",
language = "English",
volume = "21",
pages = "1306--1311",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

Feasibility and surgical outcomes of laparoscopic metastasectomy in the treatment of ovarian metastases from gastric cancer. / Lee, Maria; Paek, Jiheum; Lee, San Hui; Yim, Ga Won; Kim, Sang Wun; Kim, Sunghoon; Kim, Jae-Hoon; Kim, YoungTae; Nam, Eun Ji.

In: International Journal of Gynecological Cancer, Vol. 21, No. 7, 01.10.2011, p. 1306-1311.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Feasibility and surgical outcomes of laparoscopic metastasectomy in the treatment of ovarian metastases from gastric cancer

AU - Lee, Maria

AU - Paek, Jiheum

AU - Lee, San Hui

AU - Yim, Ga Won

AU - Kim, Sang Wun

AU - Kim, Sunghoon

AU - Kim, Jae-Hoon

AU - Kim, YoungTae

AU - Nam, Eun Ji

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Objectives: This study aimed to evaluate the feasibility of laparoscopic metastasectomy (LM) in the treatment of ovarian metastases from gastric cancer and to compare the surgical outcomes with patients who underwent open metastasectomy (OM). Methods: The cases of 73 patients who underwent LM (n = 16) or OM (n = 57) were retrospectively reviewed. All patients were diagnosed with gastric cancer and, subsequently, underwent a metastasectomy at Yonsei University Health System between December 2002 and March 2011. Results: Sixteen operations were completed laparoscopically with no conversion to laparotomy. Complete cytoreduction surgery was achievable in 13 patients (81.3%). Operating time, complete cytoreduction, and occurrence of perioperative complications were comparable between the 2 groups. The LM group had less blood loss (25 vs 400 mL, P < 0.0001), earlier return to a general diet (3 vs 4 days, P = 0.005), shorter postoperative hospital stay (4.5 vs 7 days, P < 0.0001), and lower postoperative pain scores after 6, 24, and 48 hours than those in the OM group. There were no operative complications in the LM group. Conclusions: As a surgical treatment for ovarian metastases from gastric cancer, LM is feasible and provides benefits to patients without detrimental effects on the clinical outcomes for selected patients.

AB - Objectives: This study aimed to evaluate the feasibility of laparoscopic metastasectomy (LM) in the treatment of ovarian metastases from gastric cancer and to compare the surgical outcomes with patients who underwent open metastasectomy (OM). Methods: The cases of 73 patients who underwent LM (n = 16) or OM (n = 57) were retrospectively reviewed. All patients were diagnosed with gastric cancer and, subsequently, underwent a metastasectomy at Yonsei University Health System between December 2002 and March 2011. Results: Sixteen operations were completed laparoscopically with no conversion to laparotomy. Complete cytoreduction surgery was achievable in 13 patients (81.3%). Operating time, complete cytoreduction, and occurrence of perioperative complications were comparable between the 2 groups. The LM group had less blood loss (25 vs 400 mL, P < 0.0001), earlier return to a general diet (3 vs 4 days, P = 0.005), shorter postoperative hospital stay (4.5 vs 7 days, P < 0.0001), and lower postoperative pain scores after 6, 24, and 48 hours than those in the OM group. There were no operative complications in the LM group. Conclusions: As a surgical treatment for ovarian metastases from gastric cancer, LM is feasible and provides benefits to patients without detrimental effects on the clinical outcomes for selected patients.

UR - http://www.scopus.com/inward/record.url?scp=84863276271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863276271&partnerID=8YFLogxK

U2 - 10.1097/IGC.0b013e31822620e3

DO - 10.1097/IGC.0b013e31822620e3

M3 - Review article

VL - 21

SP - 1306

EP - 1311

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 7

ER -